Following some good news for the company, Roth MKM analyst Jonathan Aschoff has maintained his “Buy” rating on Panbela Therapeutics (Panbela Therapeutics Stock Quote, Chart, News, Analysts, Financials Nasdaq:PBLA). On November 29, PBLA announced that the independent Data Safety Monitoring Board of the Phase 3 ASPIRE clinical trial for patients with untreated metastatic pancreatic ductal […]
Shares of ASEP Medical (ASEP Medical Stock Quote, Chart, News, Analysts, Financials CSE:ASEP) are leading the CSE today after the company updated its latest developments. On November 17, Victoria-based ASEP announced that it was in the final stages of the approval process to list its shares of the Nasdaq. The company, which was formed to […]
Share
Tweet
Share